Kbmp4 May 2026

Research indicates that variables like bulky disease and Ki67 are strong independent predictors of how long a patient will remain in remission.

💡 The inclusion of the P4 (Interim PET) parameter is significant because it allows doctors to adjust treatment mid-course based on how the tumor is actually responding to chemotherapy. Clinical Significance Research indicates that variables like bulky disease and

If you are looking for or comparisons to other models like the IPI or NCCN-IPI , I can provide those details. The model is a clinical scoring system used

High proliferation index (Ki67 ≥ 70%) on immunohistochemistry. B (Bulky): Physical presence of a tumor mass ≥ 7.5 cm. I can provide those details.

Documented meningeal lymphomatosis (spread to the brain or spinal cord membranes).

The model is a clinical scoring system used to predict the survival and prognosis of patients with de novo Diffuse Large B-cell Lymphoma (DLBCL) .